News
GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...
GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...
GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...
3d
Pharmaceutical Technology on MSNBharat Biotech acquires licence for GSK’s Shigella vaccine developmentThe partnership includes support for the design of the Phase III trial and assistance in securing external funding.
Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...
This Original Lifetime Movie, "Pretty Hurts," airs June 28, at 8 p.m.
What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...
GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...
IPV Vaccines Market Set to Expand at CAGR of 8.7% Through 2032 | Sanofi Pasteur, GlaxoSmithKline plc
The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...
GSK said it licensed its Shigella vaccine candidate, altaltSonflex1-2-3, to Bharat Biotech International.
Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results